论文部分内容阅读
本文要点构成慢性肾脏病分期的基础是估计肾小球滤过率(eGFR)当 eGFR 在60～89ml/min/1.73m~2之间,但缺乏其他肾脏疾病证据时,并不代表有慢性肾脏疾病,也不需要进一步检查慢性肾病患者罹患心血管疾病的风险升高基于“4-vMDBD”公式的 eGFR 和血肌酐一样,已经成为生化实验室常规报告的指标(除了那些未经验证的患者人群)eGFR 或血肌酐水平可以用于监测患者个体肾功能的变化正规的 GFR 检测主要用于对潜在的肾移植供者的肾功能进行准确评价和研究放射性同位素或碘造影剂需要多份血标本,如果肾功能下降,则采集标本的时间可能会延长至24小时
Key points in this paper The basis for making the staging of chronic kidney disease is estimating the glomerular filtration rate (eGFR). When eGFR is between 60 and 89 ml / min / 1.73 m 2, but lacking evidence of other kidney disease does not represent chronic kidney disease Disease and does not require further examination Risk of cardiovascular disease in patients with chronic kidney disease Elevated eGFR based on the formula “4-vMDBD” and serum creatinine have become indicators of routine reporting in biochemical laboratories (except those unverified Patient population) eGFR or serum creatinine levels can be used to monitor changes in kidney function in a patient’s body. Formal GFR testing is primarily used to accurately assess renal function in potential kidney transplant recipients and to study multiple blood tests for radioisotopes or iodine contrast media Specimen, if the decline in renal function, the collection of specimens may be extended to 24 hours